In a phase 1b-2 study evaluating the safety and activity of PV in combination with R-CHP in previously untreated DLBCL pts, Tilly et al. did not find an association between CD79b expression levels evaluated with an IHC score and treatment response or PFS [7]. Here, CD79B is linked to diffuse large B-cell lymphoma.